|
HY-101899-1mg
|
MedChemexpress LLC
|
Monochlorobimane [CAS 76421-73-3]
|
|
|
|
|
HY-101899-5mg
|
MedChemexpress LLC
|
Monochlorobimane [CAS 76421-73-3]
|
|
|
|
|
HY-108917-1mg
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1]
|
|
COVID-19-anti-virus
|
|
|
HY-108917-10mg
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1]
|
|
COVID-19-anti-virus
|
|
|
HY-108917-100mg
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1]
|
|
COVID-19-anti-virus
|
|
|
HY-108917-5mg
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1]
|
|
COVID-19-anti-virus
|
|
|
HY-108917-50mg
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1]
|
|
COVID-19-anti-virus
|
|
|
HY-108917-1mL
|
MedChemexpress LLC
|
Morphothiadin [CAS 1092970-12-1] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-10229-10mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-100mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-50mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-1mL
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-10mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-100mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-5mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-50mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-1mL
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-P1037-1mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-5mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-500ug
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P0171-10mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-100mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-25mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-5mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-50mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
